ARTICLE | Company News
Roche (SIX:ROG; OTCQX:RHHBY) is acquiring the remaining shares of cancer diagnostics company Foundation Medicine Inc. (NASDAQ:FMI) that it does not already own for $137 per share in cash, or $2.4 billion.
In 2015, Roche had acquired a majority stake in Foundation for $1 billion; it held a 57% stake as of March 31. The deal also included a strategic collaboration...